China Universal Asset Management Co., Ltd.
Position in AMRX — Amneal Pharmaceuticals, Inc.
CIK 1906594
SHANGHAI, F4
Position in AMRX
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$878,880
+$184,864 QoQ
Shares Held
50,773
-9.1% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#144
of 311 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026China Universal Asset Management Co., Ltd. holds $16,477,419 across 28 Drug Manufacturers - Specialty & Generic names. AMRX ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
6,755 | $3,660,061 | |
| 2 | VTRS |
Viatris Inc
|
185,339 | $2,943,183 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
16,003 | $2,697,145 | |
| 4 | ALKS |
Alkermes plc.
|
26,527 | $1,389,882 | |
| 5 | AMRX |
Amneal Pharmaceuticals, Inc.
This page
|
50,773 | $878,880 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
19,404 | $796,146 | |
| 7 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
7,369 | $471,247 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
9,237 | $429,612 |
All Filings in AMRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $878,880 | 50,773 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $694,016 | 55,834 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $645,435 | 51,225 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $551,080 | 55,053 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $509,257 | 62,949 | Shares | Sole | 2025-08-28 | |
| 2025-03-31 | $521,018 | 62,174 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $520,328 | 65,698 | Shares | Sole | 2025-01-24 | |
| No filing history on record for this holder in this stock. | ||||||